Skip to menu Skip to content Skip to footer
Professor Gabrielle Belz
Professor

Gabrielle Belz

Email: 

Overview

Background

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Availability

Professor Gabrielle Belz is:
Available for supervision

Qualifications

  • Bachelor of Veterinary Biology, The University of Queensland
  • Bachelor (Honours) of Veterinary Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland
  • Doctoral Diploma, The University of Queensland

Research impacts

Overall goals:

Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.

We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.

Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

Research interests:

Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.

Our research focuses on:

  • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
  • How protective immunity breaks down in chronic overwhelming infections
  • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.

We have developed and use a number of in vivo models of infectious diseases including:

  • Influenza
  • Herpes virus
  • Lymphocytic choriomeningitis virus (LCMV)

These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.

Works

Search Professor Gabrielle Belz’s works on UQ eSpace

294 works between 1981 and 2025

101 - 120 of 294 works

2017

Journal Article

Unusual suspects: Dancing with stromal cells

Belz, Gabrielle T. and Almeida, Francisca F. (2017). Unusual suspects: Dancing with stromal cells. Nature Immunology, 18 (6), 601-602. doi: 10.1038/ni.3741

Unusual suspects: Dancing with stromal cells

2017

Journal Article

c-Myb regulates the T-bet-dependent differentiation program in B cells to coordinate antibody responses

Piovesan, Dana, Tempany, Jessica, Di Pietro, Andrea, Baas, Inge, Yiannis, Callisthenis, O'Donnell, Kristy, Chen, Yunshun, Peperzak, Victor, Belz, Gabrielle T., Mackay, Charles R., Smyth, Gordon K., Groom, Joanna R., Tarlinton, David M. and Good-Jacobson, Kim L. (2017). c-Myb regulates the T-bet-dependent differentiation program in B cells to coordinate antibody responses. Cell Reports, 19 (3), 461-470. doi: 10.1016/j.celrep.2017.03.060

c-Myb regulates the T-bet-dependent differentiation program in B cells to coordinate antibody responses

2017

Journal Article

Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression

Poh, Ashleigh R., Love, Christopher G., Masson, Frederick, Preaudet, Adele, Tsui, Cary, Whitehead, Lachlan, Monard, Simon, Khakham, Yelena, Burstroem, Lotta, Lessene, Guillaume, Sieber, Oliver, Lowell, Clifford, Putoczki, Tracy L., O'Donoghue, Robert J. J. and Ernst, Matthias (2017). Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression. Cancer Cell, 31 (4), 563-+. doi: 10.1016/j.ccell.2017.03.006

Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression

2017

Journal Article

Eomesodermin promotes the development of Type-1 Regulatory T (TR1) cells

Zhang, Ping, Lee, Jason S., Gartlan, Kate H., Schuster, Iona S., Comerford, Iain, Varelias, Antiopi, Ullah, Md Ashik, Vuckovic, Slavica, Koyama, Motoko, Kuns, Rachel D., Locke, Kelly R., Beckett, Kirrilee J., Olver, Stuart D., Samson, Luke D., Montes de Oca, Marcela, de Labastida Rivera, Fabian, Clouston, Andrew D., Belz, Gabrielle T., Blazar, Bruce R., MacDonald, Kelli P., McColl, Shaun R., Thomas, Ranjeny, Engwerda, Christian R., Degli-Esposti, Mariapia A., Kallies, Axel, Tey, Siok-Keen and Hill, Geoffrey R. (2017). Eomesodermin promotes the development of Type-1 Regulatory T (TR1) cells. Science Immunology, 2 (10) eaah7152. doi: 10.1126/sciimmunol.aah7152

Eomesodermin promotes the development of Type-1 Regulatory T (TR1) cells

2017

Journal Article

Generation of an inducible mouse model to reversibly silence Stat3

Alorro, Mariah G., Pierce, Thomas P., Eissmann, Moritz F., Dijkstra, Christine, Dickins, Ross A., Ernst, Matthias, Buchert, Michael and Masson, Frederic (2017). Generation of an inducible mouse model to reversibly silence Stat3. Genesis, 55 (4) e23023. doi: 10.1002/dvg.23023

Generation of an inducible mouse model to reversibly silence Stat3

2017

Journal Article

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

Kedzierski, Lukasz, Tate, Michelle D., Hsu, Alan C., Kolesnik, Tatiana B., Linossi, Edmond M., Dagley, Laura, Dong, Zhaoguang, Freeman, Sarah, Infusini, Giuseppe, Starkey, Malcolm R., Bird, Nicola L., Chatfield, Simon M., Babon, Jeffrey J., Huntington, Nicholas, Belz, Gabrielle, Webb, Andrew, Wark, Peter Ab., Nicola, Nicos A., Xu, Jianqing, Kedzierska, Katherine, Hansbro, Philip M. and Nicholson, Sandra E. (2017). Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling. eLife, 6 e20444. doi: 10.7554/eLife.20444

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

2017

Journal Article

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival

Viant, Charlotte, Guia, Sophie, Hennessy, Robert J., Rautela, Jai, Pham, Kim, Bernat, Claire, Goh, Wilford, Jiao, Yuhao, Delconte, Rebecca, Roger, Michael, Simon, Vanina, Souza-Fonseca-Guimaraes, Fernando, Grabow, Stephanie, Belz, Gabrielle T., Kile, Benjamin T., Strasser, Andreas, Gray, Daniel, Hodgkin, Phillip D., Beutler, Bruce, Vivier, Eric, Ugolini, Sophie and Huntington, Nicholas D. (2017). Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival. Journal of Experimental Medicine, 214 (2), 491-510. doi: 10.1084/jem.20160869

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival

2017

Journal Article

Effector regulatory T cell differentiation and immune homeostasis depend on the transcription factor Myb

Dias, Sheila, D'Amico, Angela, Cretney, Erika, Liao, Yang, Tellier, Julie, Bruggeman, Christine, Almeida, Francisca F., Leahy, Jamie, Belz, Gabrielle T., Smyth, Gordon K., Shi, Wei and Nutt, Stephen L. (2017). Effector regulatory T cell differentiation and immune homeostasis depend on the transcription factor Myb. Immunity, 46 (1), 78-91. doi: 10.1016/j.immuni.2016.12.017

Effector regulatory T cell differentiation and immune homeostasis depend on the transcription factor Myb

2016

Journal Article

Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function

Chandra, Janin, Kuo, Paula T. Y., Hahn, Anne M., Belz, Gabrielle T. and Frazer, Ian H. (2016). Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function. Immunology and Cell Biology, 95 (2), 215-223. doi: 10.1038/icb.2016.83

Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function

2016

Journal Article

Immunology & Cell Biology Publication of the Year Awards 2015

Belz, Gabrielle (2016). Immunology & Cell Biology Publication of the Year Awards 2015. Immunology and Cell Biology, 94 (10), 901-902. doi: 10.1038/icb.2016.86

Immunology & Cell Biology Publication of the Year Awards 2015

2016

Journal Article

A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage

Koay, Hui-Fern, Gherardin, Nicholas A., Enders, Anselm, Loh, Liyen, Mackay, Laura K., Almeida, Catarina F., Russ, Brendan E., Nold-Petry, Claudia A., Nold, Marcel F., Bedoui, Sammy, Chen, Zhenjun, Corbett, Alexandra J., Eckle, Sidonia B. G., Meehan, Bronwyn, D'Udekem, Yves, Konstantinov, Igor E., Lappas, Martha, Liu, Ligong, Goodnow, Chris C., Fairlie, David P., Rossjohn, Jamie, Chong, Mark M., Kedzierska, Katherine, Berzins, Stuart P., Belz, Gabrielle T., McCluskey, James, Uldrich, Adam P., Godfrey, Dale I. and Pellicci, Daniel G. (2016). A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nature Immunology, 17 (11), 1300-1311. doi: 10.1038/ni.3565

A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage

2016

Journal Article

Type 1 innate lymphoid cell biology: Lessons learnt from natural killer cells

Jiao, Yuhao, Huntington, Nicholas D., Belz, Gabrielle T. and Seillet, Cyril (2016). Type 1 innate lymphoid cell biology: Lessons learnt from natural killer cells. Frontiers in Immunology, 7 (OCT) 426. doi: 10.3389/fimmu.2016.00426

Type 1 innate lymphoid cell biology: Lessons learnt from natural killer cells

2016

Journal Article

Deciphering the innate lymphoid cell transcriptional program

Seillet, Cyril, Mielke, Lisa A., Amann-Zalcenstein, Daniela B., Su, Shian, Gao, Jerry, Almeida, Francisca F., Shi, Wei, Ritchie, Matthew E., Naik, Shalin H., Huntington, Nicholas D., Carotta, Sebastian and Belz, Gabrielle T. (2016). Deciphering the innate lymphoid cell transcriptional program. Cell Reports, 17 (2), 436-447. doi: 10.1016/j.celrep.2016.09.025

Deciphering the innate lymphoid cell transcriptional program

2016

Journal Article

CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles

Leong, Yew Ann, Chen, Yaping, Ong, Hong Sheng, Wu, Di, Man, Kevin, Deleage, Claire, Minnich, Martina, Meckiff, Benjamin J., Wei, Yunbo, Hou, Zhaohua, Zotos, Dimitra, Fenix, Kevin A., Atnerkar, Anurag, Preston, Simon, Chipman, Jeffrey G., Beilman, Greg J., Allison, Cody C., Sun, Lei, Wang, Peng, Xu, Jiawei, Toe, Jesse G., Lu, Hao K., Tao, Yong, Palendira, Umaimainthan, Dent, Alexander L., Landay, Alan L., Pellegrini, Marc, Comerford, Iain, McColl, Shaun R. ... Yu, Di (2016). CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles. Nature Immunology, 17 (10), 1187-+. doi: 10.1038/ni.3543

CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles

2016

Journal Article

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway

Yu, Yong, Tsang, Jason C. H., Wang, Cui, Clare, Simon, Wang, Juexuan, Chen, Xi, Brandt, Cordelia, Kane, Leanne, Campos, Lia S., Lu, Liming, Belz, Gabrielle T., McKenzie, Andrew N. J., Teichmann, Sarah A., Dougan, Gordon and Liu, Pentao (2016). Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway. Nature, 539 (7627), 102-106. doi: 10.1038/nature20105

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway

2016

Journal Article

Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity

Newman, Dane M., Sakaguchi, Shinya, Lun, Aaron, Preston, Simon, Pellegrini, Marc, Khamina, Kseniya, Bergthaler, Andreas, Nutt, Stephen L., Smyth, Gordon K., Voss, Anne K., Thomas, Tim, Ellmeier, Wilfried, Belz, Gabrielle T. and Allan, Rhys S. (2016). Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity. Cell Reports, 16 (12), 3311-3321. doi: 10.1016/j.celrep.2016.08.056

Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity

2016

Journal Article

Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection

Almeida, F. F. and Belz, G. T. (2016). Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. Mucosal Immunology, 9 (5), 1103-1112. doi: 10.1038/mi.2016.64

Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection

2016

Journal Article

Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia

Ghisi, Margherita, Kats, Lev, Masson, Frederick, Li, Jason, Kratina, Tobias, Vidacs, Eva, Gilan, Omer, Doyle, Maria A., Newbold, Andrea, Bolden, Jessica E., Fairfax, Kirsten A., de Graaf, Carolyn A., Firth, Matthew, Zuber, Johannes, Dickins, Ross A., Corcoran, Lynn M., Dawson, Mark A., Belz, Gabrielle T. and Johnstone, Ricky W. (2016). Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia. Cancer Cell, 30 (1), 59-74. doi: 10.1016/j.ccell.2016.05.019

Id2 and E proteins orchestrate the initiation and maintenance of MLL-rearranged acute myeloid leukemia

2016

Journal Article

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis

Souza-Fonseca-Guimaraes, F., Krasnova, Y., Putoczki, T., Miles, K., MacDonald, K. P., Town, L., Shi, W., Gobe, G. C., McDade, L., Mielke, L. A., Tye, H., Masters, S. L., Belz, G. T., Huntington, N. D., Radford-Smith, G. and Smyth, M. J. (2016). Granzyme M has a critical role in providing innate immune protection in ulcerative colitis. Cell Death and Disease, 7 (7) e2302, e2302-e2302. doi: 10.1038/cddis.2016.215

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis

2016

Journal Article

CIS is a potent checkpoint in NK cell-mediated tumor immunity

Delconte, Rebecca B., Kolesnik, Tatiana B., Dagley, Laura F., Rautela, Jai, Shi, Wei, Putz, Eva M., Stannard, Kimberley, Zhang, Jian-Guo, Teh, Charis, Firth, Matt, Ushiki, Takashi, Andoniou, Christopher E., Degli-Esposti, Mariapia A., Sharp, Phillip P., Sanvitale, Caroline E., Infusini, Giuseppe, Liau, Nicholas P. D., Linossi, Edmond M., Burns, Christopher J., Carotta, Sebastian, Gray, Daniel H. D., Seillet, Cyril, Hutchinson, Dana S., Belz, Gabrielle T., Webb, Andrew I., Alexander, Warren S., Li, Shawn S., Bullock, Alex N., Babon, Jeffery J. ... Huntington, Nicholas D. (2016). CIS is a potent checkpoint in NK cell-mediated tumor immunity. Nature Immunology, 17 (7), 816-824. doi: 10.1038/ni.3470

CIS is a potent checkpoint in NK cell-mediated tumor immunity

Funding

Current funding

  • 2025 - 2029
    Unravelling immune signalling networks that protect vertebrates from attack
    ARC Australian Laureate Fellowships
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2026
    From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer
    Cure Cancer Early Career Research Grants
    Open grant
  • 2024 - 2026
    Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
    NHMRC Development Grant
    Open grant
  • 2024 - 2025
    Screening experimental adjuvants in non-human primates for improved Group A Streptococcus (GAS) vaccine efficacy
    The University of Queensland in America, Inc
    Open grant
  • 2023 - 2026
    Regulation of lung immune-epithelial networks sensing environmental change
    ARC Discovery Projects
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2026
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2022 - 2026
    Harnessing immune cell programs to drive immune protection
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2022 - 2024
    Determining Causative Mechanisms of Hidradenitis Suppurativa (TRI LINC grant led by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2024
    LUNG PREDICT Study
    Cancer Australia
    Open grant
  • 2022
    Generating neuroprotective IgA through microbiome-epithelial interactions
    MS Research Australia Project Grant
    Open grant
  • 2022 - 2024
    Type 2 innate lymphoid cells orchestrate anti-melanoma responses.
    Cancer Council NSW Project Grant
    Open grant
  • 2021 - 2022
    Cutaneous squamous cell carcinoma and tumour MICroenvironment Multiplex Spatial Profiling - cMIC STUDY (PA Research Foundation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2021 - 2023
    Coordinating neuroimmune sensory networks in health and disease
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2023
    New guardians of the mucosa: Molecular characterisation of M cell biology (ARC Discovery Project administered by UTS)
    University of Technology Sydney
    Open grant
  • 2020 - 2022
    Delineating immune circuits for innate and adaptive immune protection
    NHMRC Research Fellowship
    Open grant
  • 2019 - 2023
    The recirculation of myeloid dendritic cells
    ARC Discovery Projects
    Open grant
  • 2019 - 2021
    Understanding the circadian regulation of the innate lymphoid cells (NHMRC Project Grant administered by WEHI)
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant

Supervision

Availability

Professor Gabrielle Belz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Unravelling immune signalling networks in mucosal immunity

    Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.

    This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.

    Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.

    The Belz Laboratory

    The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.

    Frazer Institute at the University of Queensland

    The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.

    As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.

    The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.

    With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.

    The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au